Clinical Trials Using Gemcitabine Hydrochloride
Review the clinical trials studying gemcitabine hydrochloride on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-25 of
27
- Status: ActiveLocation: 1052 locations
- Gemcitabine Hydrochloride and Cisplatin in Treating Patients with Invasive Bladder Urothelial CancerStatus: ActiveLocation: 369 locations
- Status: ActiveLocation: 396 locations
- Status: ActiveLocation: 206 locations
- Status: ActiveLocation: 26 locations
- Status: ActiveLocation: 24 locations
- Status: ActiveLocation: 18 locations
- Status: ActiveLocation: 8 locations
- Status: ActiveLocation: 7 locations
- Status: ActiveLocation: 5 locations
- Status: ActiveLocation: 4 locations
- Status: ActiveLocation: 3 locations
- Status: ActiveLocation: 5 locations
- Status: ActiveLocation: 3 locations
- Status: ActiveLocation: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
- Status: ActiveLocation: 3 locations
- Status: ActiveLocation: 4 locations
- Status: ActiveLocation: Northwestern University, Chicago, Illinois
- Status: ActiveLocation: National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland
- Status: ActiveLocation: Mayo Clinic in Rochester, Rochester, Minnesota
- Status: ActiveLocation: Memorial Sloan Kettering Cancer Center, New York, New York
- Status: ActiveLocation: University of Virginia Cancer Center, Charlottesville, Virginia
- Status: ActiveLocation: See ClinicalTrials.gov
- Status: Temporarily Closed to AccrualLocation: M D Anderson Cancer Center, Houston, Texas
- Status: Temporarily Closed to AccrualLocation: Wake Forest University Health Sciences, Winston-Salem, North Carolina